SCHEMBL378373

SCHEMBL378373

CN1CCN(Cc2ccc(N)c(C(N)=O)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
CHEK1 O14757 1/20 0.53
PARP1 P09874 3/20 0.49
PARP2 Q9UGN5 1/20 0.49
PARP3 Q9Y6F1 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
GRM2 Q14416 1/20 0.47
CHKA P35790 3/20 0.46
CA2 P00918 2/20 0.46
NCF1 P14598 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
MC4R P32245 1/20 0.45
HSP90AA1 P07900 2/20 0.45
HSP90AB1 P08238 2/20 0.45
HRH3 Q9Y5N1 1/20 0.44
HSP90B1 P14625 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL378576 0.89 ALDH1A1 (0.55) LMNACHEK1HDAC6CHKACA2
SCHEMBL378360 0.85 ALDH1A1 (0.61) LMNACHEK1HDAC6CHKACA2
SCHEMBL145235 0.83 PARP1 (0.49) LMNAPARP1PARP2PARP3GRM2
SCHEMBL12380564 0.83 KDM4E (0.52) LMNACHEK1PARP1PARP2PARP3
Hydrochloric Acid SCHEMBL347360 0.82 PARP1 (0.48) LMNAPARP1PARP2PARP3GRM2
SCHEMBL3081902 0.80 HTT (0.56) LMNACHEK1PARP1PARP2PARP3
SCHEMBL547278 0.80 LMNA (0.66) LMNAHDAC6CHKACA2NCF1
SCHEMBL27682017 0.78 CHEK1 (0.49) LMNACHEK1PARP1PARP2PARP3
SCHEMBL2906006 0.77 HDAC6 (0.68) LMNACHEK1PARP1PARP2PARP3
SCHEMBL16178546 0.77 LMNA (0.62) LMNAHDAC6CHKACA2NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408454-B1 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP (CA) 2024-07-24 EP disclosed
US-11407719-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2022-08-09 US disclosed
US-20210070716-A1 ANTI-INFLAMMATORY AGENTS HEPALINK (HONG KONG) LIMITED (HK) 2021-03-11 US disclosed
US-10882828-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2021-01-05 US disclosed
US-20190119222-A1 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP. (CA) 2019-04-25 US disclosed
US-10131640-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2018-11-20 US disclosed
US-20160137613-A1 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP. (CA) 2016-05-19 US disclosed
US-9238640-B2 Anti-inflammatory agents RESVERLOGIX CORP. (CA) 2016-01-19 US disclosed
CN-102427813-A Novel anti-inflammatory agents RESVERLOGIX CORP 2012-04-25 CN disclosed
US-20120040954-A1 NOVEL ANTI-INFLAMMATORY AGENTS HEPALINK (HONG KONG) LIMITED (HK) 2012-02-16 US disclosed
EP-2408454-A2 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP. (CA) 2012-01-25 EP disclosed
WO-2010106436-A2 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP. (CA) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407719-B2 Anti-inflammatory agents VCAM1, ICAM1, IL6 LMNA 3612/4885CHEK1 3437/4885PARP1 1156/4885
US-20160137613-A1 NOVEL ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 LMNA 3769/4885CHEK1 3494/4885PARP1 1176/4885
US-10882828-B2 Anti-inflammatory agents VCAM1, ICAM1, IL6 LMNA 3612/4885CHEK1 3437/4885PARP1 1156/4885
US-20210070716-A1 ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 LMNA 3612/4885CHEK1 3437/4885PARP1 1156/4885
US-10131640-B2 Anti-inflammatory agents VCAM1, ICAM1, IL6 LMNA 3612/4885CHEK1 3437/4885PARP1 1156/4885
US-20190119222-A1 NOVEL ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 LMNA 3769/4885CHEK1 3494/4885PARP1 1176/4885
US-20120040954-A1 NOVEL ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 LMNA 3769/4885CHEK1 3494/4885PARP1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.